DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Combivent (Ipratropium Bromide / Albuterol Sulfate) - Current Clinical Trials

 
 



Combivent Related Clinical Trials

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Terminated]

Ipratropium Bromide/Salbutamol Delivered by the Respimat« Inhaler Compared to Ipratropium Bromide Respimat«, COMBIVENT« Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease [Completed]

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Combivent´┐Ż HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease) [Terminated]

Safety and Tolerability of COMBIVENT« HFA as Compared to COMBIVENT« CFC and Placebo HFA in Healthy Male and Female Subjects [Completed]

4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma [Completed]

Efficacy and Safety of Combivent« Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis [Terminated]

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease [Completed]

Combivent« CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma [Completed]

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. [Completed]

Ventilator Adapters for Combivent Respimat [Completed]

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) [Completed]

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent´┐Ż Inhalation Aerosol in COPD Patients. [Completed]

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm [Completed]

Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment [Completed]

Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]

Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients [Recruiting]

Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation [Completed]

Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies [Completed]

Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD [Completed]

Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease [Recruiting]

GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children [Not yet recruiting]

A Crossover Study in the Treatment of Patients With COPD [Completed]

A Comparison of Symbicort´┐Ż Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma [Completed]

Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015